Levoxyl and Appendicitis - a phase IV clinical study of FDA data

Summary:

Appendicitis is reported as a side effect among people who take Levoxyl (levothyroxine sodium), especially for people who are female, 50-59 old, also take Climara, and have Menopause.

The phase IV clinical study analyzes which people have Appendicitis when taking Levoxyl. It is created by eHealthMe based on reports of 23,566 people who have side effects when taking Levoxyl from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Appendicitis?

Appendicitis (inflammation of the appendix) is found to be associated with 833 drugs and 902 conditions by eHealthMe. Check the latest studies of Appendicitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

23,566 people reported to have side effects when taking Levoxyl.
Among them, 19 people (0.08%) have Appendicitis.

Among these 19 people:

What is the gender of people who have Appendicitis when taking Levoxyl? *

female: 84.21 %
male: 15.79 %

What is the age of people who have Appendicitis when taking Levoxyl? *

What are other drugs people take besides Levoxyl? *

What are other side effects people have besides Appendicitis? *

Nausea (feeling of having an urge to vomit): 12 people, 63.16%
Nausea And Vomiting: 10 people, 52.63%
Diaphragmatic Hernia (defect or hole in the diaphragm that allows the abdominal contents to move into the chest cavity): 8 people, 42.11%
Herpes Zoster: 8 people, 42.11%
Kidney Stones: 8 people, 42.11%
Kidney Infection (Pyelonephritis): 8 people, 42.11%
Oestrogen Receptor Assay Positive: 8 people, 42.11%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 42.11%
Pain In Extremity: 8 people, 42.11%
Breast Cancer: 8 people, 42.11%

What are the existing conditions these people have? *

Menopause (end of monthly cycles in women): 8 people, 42.11%
Pneumonia: 2 people, 10.53%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 10.53%
Osteoporosis (bones weak and more likely to break): 2 people, 10.53%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
Type 1 Diabetes: 1 person, 5.26%
Premenstrual Syndrome: 1 person, 5.26%
Pain: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
Heart Rate Increased: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and have Appendicitis?

- Check whether Appendicitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levoxyl:

Levoxyl (25,178 reports)

Appendicitis treatments and more:

Appendicitis (11,953 reports)

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appendicitis:

Appendicitis (833 drugs)

Browse all the conditions that are associated with Appendicitis:

Appendicitis (902 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levoxyl) and Levoxyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.